The largest database of trusted experimental protocols

14 protocols using piericidin a

1

Caco-2 Monolayer Permeability Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fourteen-days differentiated Caco-2 cells were used for monolayer permeability experiments, which were all performed in triplicate. Caco-2 cells were incubated with varying concentrations of either vehicle (96% EtOH), CCCP (mitochondrial uncoupler, 0-1-2-3-4-5 μM), rotenone (ROT, Complex I inhibitor, 0-50-100-200 nM), and Piericidin A (PA, Complex I inhibitor, 0-50-100-200 nM; Cayman Chemicals, Ann Arbor, MI, USA) for 27, 30, and 42 h, respectively. Changes in TEER were followed over time to determine permeability of the Caco-2 monolayer. Apical medium was harvested to determine cytotoxicity with the Pierce LDH Cytotoxicity assay kit (Thermo Scientific), according to the manufacturer's instructions.
One hundred μg/mL fluorescein (Sigma Aldrich) was added to the apical medium of Caco-2 cells incubated with vehicle (96% EtOH) or 200 nM PA for 24 h prior to harvesting the basolateral medium at different time points. Caco-2 cells incubated with vehicle (96% EtOH) or 200 nM PA were also harvested at different time points to determine cellular energy status and to isolate RNA for gene expression analysis.
+ Open protocol
+ Expand
2

Seahorse Analysis of Lung Epithelial Cell Respiration

Check if the same lab product or an alternative is used in the 5 most similar protocols
The OCR of lung epithelial cells was measured in a Seahorse XF96 extracellular flux analyser (Agilent Bioscience) with Wave v.2.6.3.5 software. Isolated lung epithelial cells as described above were immediately seeded at 7.5 × 104 cells per well using cell adhesive, Cell-Tak (Corning, catalogue no. 354240) according to the manufacturer’s instructions. Basal mitochondrial respiration was assessed by subtracting the non-mitochondrial OCR, measured with 1 μM antimycin A (Sigma, catalogue no. A8674) and 1 μM piericidin A (Cayman, catalogue no. 15379), from baseline OCR. Coupled respiration was determined by subtracting the OCR in the presence of 2 μΜ oligomycin (Sigma, catalogue no. 75351) from the basal mitochondrial respiration.
+ Open protocol
+ Expand
3

Measurement of NADH-Dependent Enzyme Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
NADH:ferricyanide (FeCy), NADH:ubiquinone-1 (Q1), and NADH:decylubiquinone (DQ) activities were measured as described previously (Sazanov et al., 2003 (link)). NADH:FeCy and NADH:Q1 activities of the nanodisc-reconstituted sample were assayed in the buffer containing 10 mM Bis-Tris pH 6.8, 200 mM NaCl, and 10 mM CaCl2. To increase the solubility of DQ during NADH:DQ assays the assay buffer was supplemented with a small amount of LMNG (0.003%). All the assays for the LMNG-purified sample were performed in the LMNG activity buffer containing 10 mM Bis-Tris pH 6.0, 25 mM NaCl, 10 mM CaCl2, and 0.1% LMNG.
For the NADH:FeCy assay, 0.9 nM of complex I and 1 mM FeCy (Sigma Aldrich BVBA) was added to the assay buffer in a stirred quartz cuvette. For the NADH:Q1/DQ, 3–9 nM of detergent-solubilized or nanodisc-reconstituted complex I and 100 μM Q1/DQ (Sigma Aldrich BVBA) was added to the assay buffer in a stirred quartz cuvette at 30°C and incubated for 5 min. The reactions were initiated by adding 100 μM NADH (Carl-Roth GmbH) and followed as reduction in absorbance at 340 nm using a Varian Cary 300 UV-Vis spectrophotometer (Agilent Technologies, Inc). To perform the inhibition assay, 20 µM Piericidin A (Cayman Chemical) was added during the NADH:Q1 or NADH:DQ reaction.
+ Open protocol
+ Expand
4

Spectrophotometric Assays for Respiratory Chain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Assays were performed using 96-well plates in a Molecular Devices Spectramax M2 spectrophotometer. The following specialized reagents and manufacturers were used as needed: NADH (MilliporeSigma), dNADH (nicotinamide hypoxanthine dinucleotide, MilliporeSigma) cyt c purified from equine heart (MilliporeSigma), FeCy (MilliporeSigma) decylubiquinone (DQ; Santa Cruz Biotechnology), antimycin A (MilliporeSigma), piericidin A (Cayman Chemicals), superoxide dismutase (MilliporeSigma) and KCN (Honeywell). NADH oxidation was measured at 340 nm; cyt c reduction was measured at 550 nm. The path length of our reaction in the 96-well plates, and the extinction coefficients of NADH and cyt c used in activity calculations were experimentally determined (see below). An extinction coefficient of 5.4 mM−1 cm−1 was used for NADH and dNADH; an extinction coefficient of 6.5 mM−1 cm−1 was used for reduced–oxidized cytochrome c. The path length of our assay was 0.531 cm. Measurements of initial rates were done in replicates (detailed below), averaged and background corrected. Figures show averages and standard error from the mean.
+ Open protocol
+ Expand
5

Biochemical Reagents for Cell Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial lipopolysaccharide (LPS), iodoacetic acid (IAA), 2-deoxyglucose (2DG), indomethacin, 2-thenoyltrifluoroacetone (TTFA), oligomycin, rotenone, antimycin A and myxothiazol were from Sigma Aldrich (St. Louis, MO, USA). GKT137831, zileuton, PD146176, idebenone, piericidin A, trifluoromethoxy carbonylcyanide phenylhydroazone (FCCP), S-ethyl isothiourea (SEITU) and 1400W were from Cayman Chemical (Ann Arbor, MI, USA). GSK2795039 was from MedChem Express (Monmouth Junction, NJ, USA). All other chemicals were from Sigma Aldrich.
+ Open protocol
+ Expand
6

Inhibition of Mitochondrial ETC Complexes in Osteoclastogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mitochondrial ETC complex I inhibitor piericidin A (#15379) and complex II inhibitor atpenin A5 (#11898) were purchased from Cayman Chemical, while complex III inhibitor myxothiazol (T5580) was purchased from MilliporeSigma. Cultured BMM were treated with DMSO (control group), piericidin A (0.2 μM), atpenin A5 (0.4 μM), myxothiazol (0.2 μM), or antimycin (0.2 μM) along with methyl-pyruvate (1 mM) and uridine (400 μM) followed by RANKL stimulation. All concentrations were referred to published papers (42 (link), 43 (link)) and optimized for BMM treatment. TRAP staining was performed when mature OCs appeared in the control group.
+ Open protocol
+ Expand
7

Quantitative PCR of LPS-treated BMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantitative PCR reverse transcription (qRT–PCR) was performed on BMDMs treated with 100 ng ml–1 ultrapure O5:B55 LPS (Invivogen, catalog no. tlrl-pb5lps) for 4 h. Before stimulation, BMDMs were treated for 30 min with piericidin A (Cayman Chemical, catalog no. 15379), myxothiazol (Sigma, catalog no. T5580), FCCP (Sigma, catalog no. C2920), oligomycin (Sigma, catalog no. 75351) or dimethyl malonate (Sigma, catalog no. 136441), as indicated in figures and figure legends.
RNA was extracted from peritoneal macrophages or BMDMs using the Omega E.Z.N.A. RNA Isolation Kit (Omega Biologicals, catalog no. R6834-02). RNA was quantified using a Nanodrop 2000 UV-visible spectrophotometer, and 300 ng of RNA was reverse transcribed using RETROscript first-strand synthesis kit (ThermoFisher, catalog no. AM17-10). Real-time PCR was performed on a BioRadCFX using iQ SYBR green Supermix (Bio-Rad, catalog no. 1708880). The following primers were used: IL-1β (forward 5′- TGGCAACTGTTCCTG-3′; reverse 3′-GGAAGCAGCCCTTCATCTTT-5′); NDI1 (forward 5′-GCCGAAGAAGTCCAAATTCAC-3′; reverse 3′- CGACAGCCGTTCTCAGAT-5′); b-Actin (forward 5′-CTAAGGCCAACCGTGAAAA-3′; reverse 3′-ACCAGAGGCATACAGGGACA-5′). Fold changes in gene expression relative to untreated control were calculated by the ΔΔCt method using mouse actin as an endogenous control for mRNA expression.
+ Open protocol
+ Expand
8

qRT-PCR Analysis of LPS-Induced Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
qRT-PCR was performed on BMDMs treated with 100ng/mL ultrapure O5:B55 LPS (Invivogen, tlrl-pb5lps) for 4 hours. Prior to stimulation, BMDMs were treated for 30 minutes with piericidin A (Cayman Chemical, 15379), myxothiazol (Sigma, T5580), Trifluoromethoxy carbonylcyanide phenylhydrazone (FCCP; Sigma, C2920) oligomycin (Sigma, 75351), or dimethyl malonate (Sigma, 136441), as indicated in figures and figure legends.
RNA was extracted from peritoneal macrophages or BMDMs using the Omega E.Z.N.A. RNA Isolation Kit (Omega Biologicals, R6834-02). RNA was quantified using a Nanodrop 2000 UV-visible spectrophotometer, and 300ng of RNA was reverse transcribed using RETROscript first-strand synthesis kit (Thermo Fisher, AM17-10). Real-time PCR was performed on a BioRadCFX using iQ SYBR green Supermix (Bio-Rad, 1708880). The following primers were used: IL-1β (Fwd 5’- TGGCAACTGTTCCTG-3’ Rev 3’-GGAAGCAGCCCTTCATCTTT-5’); NDI1 (Fwd 5’-GCCGAAGAAGTCCAAATTCAC-3’ Rev 3’- CGACAGCCGTTCTCAGAT-5’); b-Actin (Fwd 5’-CTAAGGCCAACCGTGAAAA-3’ Rev 3’-ACCAGAGGCATACAGGGACA-5’). Fold changes in gene expression relative to untreated control were calculated by the ΔΔCt method using mouse actin as an endogenous control for mRNA expression.
+ Open protocol
+ Expand
9

Comprehensive Pharmacological Inhibitor Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Actinomycin D (Sigma-Aldrich, A1410), actinomycin X2 (Adipogen, BVT-0375), antimycin A (Sigma-Aldrich, A8674), bafilomycin A1 (Cayman Chemical, 11038), bafilomycin B1 (Cayman Chemical, 14005), cycloheximide (ACROS Organics, AC357420010), filipin complex (Sigma-Aldrich, F9765), nigericin sodium salt (Cayman Chemical, 11437), nactins mixture (Cayman Chemical, 19468), novobiocin sodium salt (Calbiochem, 491207), piericidin A (Cayman Chemical, 15379), rubiginone B2 (Santa Cruz Biotechnology, sc-212793), and STA-21 (Sigma-Aldrich, SML2161).
+ Open protocol
+ Expand
10

SHIN1-Mediated Metabolic Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The small molecules methotrexate (Selleckchem, S1210), hypoxanthine (Sigma, H9636), thymidine (Sigma, T1895), and sodium formate (Fisher Scientific, S648-500) were used. The dual SHMT1/2 inhibitor SHIN1 (Tocris, 6998) was used at the concentration of 10 µM. In total, 1 mM of sodium formate was used to demonstrate on-target effects of SHIN1. Glutamylcysteine synthetase inhibitor l-buthionine-sulfoximine (BSO; Sigma, 83730-53-4) was used at the concentration of 10 µM. Mitochondrial complex I inhibitor Piericidin A (Cayman, 15379) was used at the concentration of 0.1 µM. Brequinar (Cayman, 24445) was used at the concentration of 1 µm and 10 µM. Glucose-free media containing galactose was prepared by supplementing 25 mM galactose (Sigma, G5388) into glucose-free DMEM (#11966025, ThermoFisher) with 10% dialyzed FBS (#26400044, ThermoFisher). Cells were always treated with small molecules or special media 2 h prior to infection. Samples were harvested at 48 hpi.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!